Orient Europharma Co Ltd
Orient EuroPharma Co., Ltd., a pharmaceutical company, develops and manufactures drugs worldwide. Its prescription medicines include cardiovascular, metabolism, neurology, obstetrics and gynecology, respiratory, andrology, immunology, antibiotic, and anti-cancer drugs. The company also provides nutrition and baby care products, such as milk under the Karihome brand name; and healthcare supplement… Read more
Market Cap & Net Worth: Orient Europharma Co Ltd (4120)
Orient Europharma Co Ltd (TWO:4120) has a market capitalization of $12.73K (NT$421.20K) as of March 18, 2026. Listed on the TWO stock exchange, this Taiwan-based company holds position #21827 globally and #1226 in its home market, demonstrating a 5.35% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Orient Europharma Co Ltd's stock price NT$46.25 by its total outstanding shares 9107 (9.11K).
Orient Europharma Co Ltd Market Cap History: 2015 to 2026
Orient Europharma Co Ltd's market capitalization history from 2015 to 2026. Data shows growth from $12.86K to $12.73K (0.94% CAGR).
Orient Europharma Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Orient Europharma Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
Orient Europharma Co Ltd's market cap is 0.00 times its annual revenue
1.02x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $12.86K | $4.91 Billion | $223.16 Million | 0.00x | 0.00x |
| 2016 | $13.81K | $5.23 Billion | $469.61 Million | 0.00x | 0.00x |
| 2017 | $18.06K | $5.23 Billion | $458.73 Million | 0.00x | 0.00x |
| 2018 | $12.37K | $5.51 Billion | $246.74 Million | 0.00x | 0.00x |
| 2019 | $13.59K | $6.09 Billion | $247.66 Million | 0.00x | 0.00x |
| 2020 | $12.18K | $5.38 Billion | $199.30 Million | 0.00x | 0.00x |
| 2021 | $9.56K | $4.77 Billion | $120.17 Million | 0.00x | 0.00x |
| 2022 | $9.76K | $4.73 Billion | -$310.80 Million | 0.00x | N/A |
| 2023 | $10.49K | $4.59 Billion | $143.94 Million | 0.00x | 0.00x |
| 2024 | $13.27K | $4.39 Billion | -$283.93 Million | 0.00x | N/A |
Competitor Companies of 4120 by Market Capitalization
Companies near Orient Europharma Co Ltd in the global market cap rankings as of March 18, 2026.
Key companies related to Orient Europharma Co Ltd by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #410 globally with a market cap of $53.52 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #457 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #721 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #410 | Zoetis Inc | NYSE:ZTS | $53.52 Billion | $121.68 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.60 |
| #457 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #721 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Orient Europharma Co Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Orient Europharma Co Ltd's market cap moved from $12.86K to $ 12.73K, with a yearly change of 0.94%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | NT$12.73K | +3.24% |
| 2025 | NT$12.33K | -7.05% |
| 2024 | NT$13.27K | +26.44% |
| 2023 | NT$10.49K | +7.46% |
| 2022 | NT$9.76K | +2.13% |
| 2021 | NT$9.56K | -21.52% |
| 2020 | NT$12.18K | -10.34% |
| 2019 | NT$13.59K | +9.88% |
| 2018 | NT$12.37K | -31.54% |
| 2017 | NT$18.06K | +30.76% |
| 2016 | NT$13.81K | +7.38% |
| 2015 | NT$12.86K | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Orient Europharma Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $12.73K USD |
| MoneyControl | $12.73K USD |
| MarketWatch | $12.73K USD |
| marketcap.company | $12.73K USD |
| Reuters | $12.73K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.